The impact of asymptomatic atrial fibrillation**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
- 4 January 2004
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (1), 53-54
- https://doi.org/10.1016/j.jacc.2003.10.013
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Asymptomatic or “Silent” Atrial FibrillationCirculation, 2003
- Management of atrial tachyarrhythmias: benefits of pacemaker diagnostics.Pacing and Clinical Electrophysiology, 2003
- Beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias?Journal of the American College of Cardiology, 2000
- Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA studyPacing and Clinical Electrophysiology, 1998
- Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.Circulation, 1994
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring studyAmerican Heart Journal, 1992
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990